Libya HIV AIDS Industry Outlook 2022 - 2026

See how Libya HIV AIDS performed compared to key markets such as South Africa, Nigeria and Mozambique.

Key Market Indicators

The prevalence of HIV/AIDS among people aged 0-14 in Libya is expected to rise to around 600 by 2026. This is up from around 530 in 2021, an increase of 2.2% year-on-year. Since 1995, the prevalence has been rising by 1% annually. In 2021, Libya was ranked 77th in the world, with Guyana overtaking it in the rankings with 530 cases. Nigeria, Mozambique and Tanzania were the second, third and fourth-ranked countries respectively. By 2026, the treatment coverage of HIV/AIDS among people living with the virus in Libya is expected to reach 62%. This is up from 53% in 2021, an increase of 2.1 points year-on-year. Since 2005, the market has decreased by 1.4 points year-on-year. In 2021, Libya was ranked 100th in the world, with Montenegro overtaking it in the rankings with 53%. Cape Verde, Latvia and Zimbabwe were the second, third and fourth-ranked countries respectively.

Libya HIV AIDS Market Data and Forecasts

How much will Libya HIV AIDS Market grow to 2026?

Forecast: Incidence of Tuberculosis (Including HIV-Positive Cases) in Libya
Forecast: Incidence of HIV Among People Aged 15-24 in Libya

Other Top Countries about HIV AIDS